<i>Francisella tularensis</i> Live Vaccine Strain training of murine alveolar and bone marrow-derived macrophages. [PDF]
Khan H, Bhargava V, Elkins KL.
europepmc +1 more source
Development of a multi-epitope vaccine from outer membrane proteins and identification of novel drug targets against <i>Francisella tularensis</i>: an <i>In Silico</i> approach. [PDF]
Moradkasani S +7 more
europepmc +1 more source
Confirmed Case of Longstanding Respiratory Francisella tularensis holarctica Infection: Nebraska, 2022. [PDF]
Birn R +7 more
europepmc +1 more source
Polyaminated, acetylated and stop codon readthrough of recombinant Francisella tularensis universal stress protein in Escherichia coli. [PDF]
Girardo B +4 more
europepmc +1 more source
Comparative Review of Francisella tularensis and Francisella novicida [PDF]
Francisella tularensis is the causative agent of the acute disease tularemia. Due to its extreme infectivity and ability to cause disease upon inhalation, F. tularensis has been classified as a biothreat agent. Two subspecies of F. tularensis, tularensis and holarctica, are responsible for tularemia in humans. In comparison, the closely related species
Luke C Kingry, Jeannine M Petersen
exaly +3 more sources
Related searches:
Francisella tularensis aortitis
Infection, 2015Francisella tularensis, the agent of tularemia, is a Gram-negative coccobacillus primarily pathogen for animals and occasionally for humans. The clinical manifestations of tularemia include pneumonia, ulceroglandular, oropharyngeal, or typhoidal disease. Rare manifestations are also described, but to our knowledge, we describe here the first case of F.
Briére, M. +8 more
openaire +4 more sources
Francisella tularensis vaccines
Vaccine, 2009Francisella tularensis has attracted attention historically as a biological weapon, due to its high infectivity in aerosols, and the severity of disease in humans. There is no licensed vaccine currently available, although an attenuated live vaccine strain (LVS) was identified in the middle of the last century and has been successfully used to protect ...
openaire +2 more sources
Vaccination strategies for Francisella tularensis
Advanced Drug Delivery Reviews, 2005Francisella tularensis is the etiologic agent of tularemia, a severe debilitating disease of humans and animals. The low infectious dose of F. tularensis in humans and the relative ease of culture are probably the properties which originally attracted interest in this bacterium as a bioweapon. Even today, F. tularensis is ranked as one of the pathogens
Karen E, Isherwood +4 more
openaire +2 more sources
Field Detection of Francisella tularensis
Scandinavian Journal of Infectious Diseases, 2000A field investigation was undertaken following an outbreak of water-borne tularemia in Northern Norway. Francisella tularensis bacterial cellular components were analysed by rapid immunochromatography (RI)-testing, enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR).
B P, Berdal +7 more
openaire +2 more sources
Vaccines Against Francisella Tularensis
Annals of the New York Academy of Sciences, 2007Abstract: Francisella tularensis is one of the most pathogenic pathogens known, especially when disseminated as a small particle aerosol. Because of this, it was developed into a biological warfare agent by several states during the 20th century.
Conlan, J. Wayne, Oyston, Petra C.F.
openaire +3 more sources

